Q1 2024: MEDICLIN Boosts Consolidated Sales and Operating Results

• MEDICLIN AG increased its consolidated sales for the first quarter of 2024 by 4.9% to EUR 185.4 million.
• The Group's EBIT of EUR 4.1 million was significantly higher than the same period of the previous year (EUR -1.7 million).
• The capacity utilization rate was up on the previous year at 85.1% (3M 2023: 82.4%).
• MEDICLIN completed the sale of the former MEDICLIN Herzzentrum Coswig on 1 April and signed the purchase agreement for the Reha-Klinik am Sendesaal in Bremen on 5 April.
• In the post-acute segment, sales increased by 6.4% to € 112.7 million and the segment operating profit was € 3.0 million higher than in the same period of the previous year.
• The acute segment reported an increase in segment sales of EUR 0.6 million or 0.9% and the segment operating profit was EUR -1.3 million after EUR -4.7 million in the first quarter of 2023.

The price of MEDICLIN at the time of the news was 2,8100EUR and was up +0,36 % compared with the previous day.

MEDICLIN

-0,69 %

-1,38 %

+5,93 %

+10,00 %

-5,92 %

-33,80 %

-45,52 %

-74,12 %

ISIN:DE0006595101WKN:659510

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• Max